• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区糖尿病肾病的流行病学特征。

Epidemiological characteristics of diabetic kidney disease in Taiwan.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3.

DOI:10.1111/jdi.13668
PMID:34529360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8668071/
Abstract

Diabetic kidney disease (DKD) is a critical microvascular complication of diabetes. With the continuous increase in the prevalence of diabetes since 2000, the prevalence of DKD has also been increasing in past years. The prevalence of DKD among individuals with type 2 diabetes in Taiwan increased from 13.32% in 2000 to 17.92% in 2014. The cumulative incidence of DKD among individuals with type 1 diabetes in Taiwan was higher than 30% during 1999-2012. DKD is the leading cause of end-stage renal disease (ESRD), with a prevalence of approximately 45% in a population on chronic dialysis in Taiwan. Among individuals with type 2 diabetes, the prevalence of ESRD in the receipt of dialysis also increased from 1.32% in 2005 to 1.47% in 2014. Risk factors for DKD development are age, race, family history, hyperglycemia, hypertension, dyslipidemia, dietary patterns, and lifestyles. Prognostic factors that aggravate DKD progression include age, family history, sex, glycemic control, blood pressure (BP), microvascular complications, and atherosclerosis. This review summarizes updated information on the onset and progression of DKD, particularly in the Taiwanese population. Translating these epidemiological features is essential to optimizing the kidney care and improving the prognosis of DKD in Asian populations.

摘要

糖尿病肾病(DKD)是糖尿病的一种严重微血管并发症。自 2000 年以来,随着糖尿病患病率的不断增加,过去几年 DKD 的患病率也在不断上升。台湾 2 型糖尿病患者 DKD 的患病率从 2000 年的 13.32%上升到 2014 年的 17.92%。台湾 1999-2012 年期间,1 型糖尿病患者 DKD 的累积发病率高于 30%。DKD 是终末期肾病(ESRD)的主要原因,在台湾接受慢性透析的人群中,其患病率约为 45%。在 2 型糖尿病患者中,接受透析的 ESRD 患病率也从 2005 年的 1.32%上升到 2014 年的 1.47%。DKD 发展的危险因素包括年龄、种族、家族史、高血糖、高血压、血脂异常、饮食模式和生活方式。加重 DKD 进展的预后因素包括年龄、家族史、性别、血糖控制、血压(BP)、微血管并发症和动脉粥样硬化。本综述总结了 DKD 发病和进展的最新信息,特别是在台湾人群中。翻译这些流行病学特征对于优化亚洲人群的肾脏护理和改善 DKD 的预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/8668071/86c30b871643/JDI-12-2112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/8668071/86c30b871643/JDI-12-2112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/8668071/86c30b871643/JDI-12-2112-g002.jpg

相似文献

1
Epidemiological characteristics of diabetic kidney disease in Taiwan.台湾地区糖尿病肾病的流行病学特征。
J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3.
2
Diabetes-related end-stage renal disease in Austria 1965-2013.1965 - 2013年奥地利的糖尿病相关终末期肾病
Nephrol Dial Transplant. 2015 Nov;30(11):1920-7. doi: 10.1093/ndt/gfv113. Epub 2015 May 13.
3
Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.肥胖在糖尿病肾病中起因果作用的遗传学证据。
Diabetes. 2015 Dec;64(12):4238-46. doi: 10.2337/db15-0254. Epub 2015 Aug 25.
4
The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.沙特糖尿病肾病研究(沙特-DKD):临床特征与生化参数
Ann Saudi Med. 2018 Jan-Feb;38(1):46-56. doi: 10.5144/0256-4947.2018.03.01.1010. Epub 2018 Jan 3.
5
Diabetic Nephropathy: An Overview.糖尿病肾病概述
Methods Mol Biol. 2020;2067:3-7. doi: 10.1007/978-1-4939-9841-8_1.
6
Lifetime benefits of early detection and treatment of diabetic kidney disease.糖尿病肾病早期检测和治疗的终身获益。
PLoS One. 2019 May 31;14(5):e0217487. doi: 10.1371/journal.pone.0217487. eCollection 2019.
7
Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.机器学习算法在 2 型糖尿病合并糖尿病肾病患者终末期肾病风险预测模型中的开发与内部验证。
Ren Fail. 2022 Dec;44(1):562-570. doi: 10.1080/0886022X.2022.2056053.
8
Diabetic kidney disease: a report from an ADA Consensus Conference.糖尿病肾病:ADA 共识会议报告。
Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.
9
2023 Diabetic Kidney Disease Fact Sheet in Korea.2023 年韩国糖尿病肾病情况说明书。
Diabetes Metab J. 2024 May;48(3):463-472. doi: 10.4093/dmj.2023.0310. Epub 2024 Mar 19.
10
Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease.早发 2 型糖尿病是糖尿病肾病患者终末期肾病的危险因素。
Prev Chronic Dis. 2020 Jul 2;17:E50. doi: 10.5888/pcd17.200076.

引用本文的文献

1
Exploring the Incidence and Risk Factors of Diabetic Nephropathy in Type 1 Diabetes: Insights from a Retrospective Cohort Study in Northwest China.探索1型糖尿病患者糖尿病肾病的发病率及危险因素:来自中国西北一项回顾性队列研究的见解
Diabetes Metab Syndr Obes. 2025 Jul 8;18:2267-2276. doi: 10.2147/DMSO.S527431. eCollection 2025.
2
Associations of Dietary Protein Intake and Amino Acid Patterns with the Risk of Diabetic Kidney Disease in Adults with Type 2 Diabetes: A Cross-Sectional Study.2型糖尿病成年患者膳食蛋白质摄入量和氨基酸模式与糖尿病肾病风险的关联:一项横断面研究
Nutrients. 2025 Jun 29;17(13):2168. doi: 10.3390/nu17132168.
3

本文引用的文献

1
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.KDIGO 2021慢性肾脏病血压管理临床实践指南
Kidney Int. 2021 Mar;99(3S):S1-S87. doi: 10.1016/j.kint.2020.11.003.
2
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
3
Association of unhealthy dietary behaviors with renal function decline in patients with diabetes.
Comparative Effects of Dulaglutide and Semaglutide on Renal Function Decline and Proteinuria Reduction in Diabetic Patients: A Retrospective Cohort Study.
度拉糖肽与司美格鲁肽对糖尿病患者肾功能下降和蛋白尿减少的比较效果:一项回顾性队列研究
J Clin Med. 2025 Jun 16;14(12):4287. doi: 10.3390/jcm14124287.
4
The multifaceted modulations by dapagliflozin in preventing hyperglycemia-induced diabetic nephropathy through glucose transporters and PPARα.达格列净通过葡萄糖转运蛋白和过氧化物酶体增殖物激活受体α(PPARα)对预防高血糖诱导的糖尿病肾病的多方面调节作用。
J Diabetes Metab Disord. 2025 Jun 20;24(2):154. doi: 10.1007/s40200-025-01670-0. eCollection 2025 Dec.
5
Microvascular Complications and Cancer Risk in Type 2 Diabetes: A Population-Based Study.2型糖尿病的微血管并发症与癌症风险:一项基于人群的研究。
Cancers (Basel). 2025 May 23;17(11):1760. doi: 10.3390/cancers17111760.
6
Exploring the genomic and transcriptomic profiles of glycemic traits and drug repurposing.探索血糖性状的基因组和转录组图谱以及药物再利用。
J Biomed Sci. 2025 May 21;32(1):50. doi: 10.1186/s12929-025-01137-7.
7
The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions.亚洲地区慢性肾脏病的负担:证据综述、当前挑战及未来方向
Kidney Res Clin Pract. 2025 May;44(3):411-433. doi: 10.23876/j.krcp.23.194. Epub 2024 Sep 9.
8
Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus.钠-葡萄糖共转运蛋白 2 抑制剂与系统性红斑狼疮患者肾炎。
JAMA Netw Open. 2024 Jun 3;7(6):e2416578. doi: 10.1001/jamanetworkopen.2024.16578.
9
Design of Machine Learning Algorithms and Internal Validation of a Kidney Risk Prediction Model for Type 2 Diabetes Mellitus.2型糖尿病肾脏风险预测模型的机器学习算法设计与内部验证
Int J Gen Med. 2024 May 20;17:2299-2309. doi: 10.2147/IJGM.S449397. eCollection 2024.
10
Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.近期诊断为 2 型糖尿病患者发生早期慢性肾脏病的决定因素:来自台湾糖尿病注册研究的回顾性研究。
BMC Nephrol. 2024 Apr 15;25(1):133. doi: 10.1186/s12882-024-03567-1.
糖尿病患者不健康的饮食行为与肾功能下降的关系。
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000743.
4
Diabetes-related kidney, eye, and foot disease in Taiwan: An analysis of nationwide data from 2005 to 2014.台湾地区糖尿病相关的肾脏、眼睛和足部疾病:2005 年至 2014 年全国数据分析。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S103-S110. doi: 10.1016/j.jfma.2019.07.027. Epub 2019 Aug 30.
5
Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan.2005 年至 2014 年台湾地区糖尿病患病率和发病率趋势。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S66-S73. doi: 10.1016/j.jfma.2019.06.016. Epub 2019 Jul 9.
6
Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes.代谢综合征的危险因素可预测 2 型糖尿病患者糖尿病肾病的进展。
Diabetes Res Clin Pract. 2019 Jul;153:6-13. doi: 10.1016/j.diabres.2019.04.022. Epub 2019 May 4.
7
Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.中药使用与糖尿病肾病患者的终末期肾病和死亡率降低相关:一项基于人群的队列研究。
BMC Complement Altern Med. 2019 Apr 3;19(1):81. doi: 10.1186/s12906-019-2491-y.
8
The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy.血清白蛋白水平与糖尿病肾病患者的肾脏预后相关。
J Diabetes Res. 2019 Feb 17;2019:7825804. doi: 10.1155/2019/7825804. eCollection 2019.
9
Diabetic Retinopathy as a Risk Factor for Chronic Kidney Disease Progression: A Multicenter Case⁻Control Study in Taiwan.糖尿病视网膜病变作为慢性肾脏病进展的危险因素:台湾的一项多中心病例对照研究。
Nutrients. 2019 Feb 27;11(3):509. doi: 10.3390/nu11030509.
10
The spectrum of kidney biopsy findings in patients with morbid obesity.病态肥胖患者肾活检结果的分布情况。
Kidney Int. 2019 Mar;95(3):647-654. doi: 10.1016/j.kint.2018.11.026. Epub 2019 Jan 31.